The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida
BPC-157 Alternatives Without Theoretical Cancer Risk: Pro-Angiogenic Concerns and Safer Peptide Options BPC-157 promotes blood vessel growth in animal studies, raising theoretical concerns about feeding occult tumors

Ingridients Water, Butylene Glycol, Beeswax, Caprylic/Capric Triglyceride, Niacinamide, Cetearyl Alcohol, Isononyl Isononanoate, Arachidyl Alcohol, 1,2-Hexanediol, Polyglyceryl-3 Methylglucose Distearate, Behenyl Alcohol, Glyceryl Stearate, Betaine, Arachidyl Glucoside, Cetearyl Olivate, Allantoin, Sorbitan Olivate, Panthenol, Hydrogenated Lecithin, Tocopherol, Xanthan Gum, Glycerin, Glutathione(600 ppm), Ethylhexylglycerin, Dipotassium Glycyrrhizate, Stearic Acid, Disodium EDTA, Bisabolol, Sodium Hyaluronate, Ascorbyl Tetraisopalmitate, Glucose, Alcohol, Malva Sylvestris (Mallow) Extract, Melissa Officinalis Leaf Extract, Alchemilla Vulgaris Extract, Achillea Millefolium Extract, Veronica Officinalis Extract, Mentha Piperita (Peppermint) Leaf Extract, Primula Veris Extract, Polyglyceryl-10 Stearate, Ceramide NP, Sodium Ascorbyl Phosphate, Ceramide NS, Cholesterol, Phytosphingosine, Ceramide AP, Ceramide AS, Sodium Hydroxide, Biotin, Acetyl Hexapeptide-8, Copper Tripeptide-1, Pyridoxine, Oligopeptide-29, Oligopeptide-32, Cyanocobalamin, Palmitoyl Pentapeptide-4, Ceramide EOP, Riboflavin, Beta-Carotene, Thiamine HCl, Fragrance Reviews There are no reviews yet.

Identification of a novel class of insect glutathione S-transferases involved in resistance to DDT in the malaria vector Anopheles gambiae
NovaRX harnesses BPC-157, an advanced healing peptide produced in top-tier U.S